In the data set of clinically ascertained NOTCH3lof cases, ascertainment bias has likely contributed to a higher reported stroke incidence because in the clinical setting, only patients with a CADASIL-like phenotype will receive NOTCH3 genetic testing. This evidence concerns the gene NOTCH3 and stroke disorder.